The ability to cause defects in a developing fetus. This is distinct from mutagenicity, which causes genetic mutations in sperms, eggs or other cells. Teratogenicity is a potential side effect of many drugs, such as thalidomide.
The ability of a substance to produce irreversible birth defects or anatomical or functional disorders as a result of an effect on the developing embryo or fetus.
The ability of a drug to cause damage to a developing fetus.
the ability to cause malformation of the fetus (birth defects).
The quality of being teratogenic, i.e., the tendency to cause malformations of the embryo or fetus or birth defects.
The property or capability of producing fetal malformation.
the ability of a chemical substance to cause malformations in a human or animal fetus.
Potential to cause or the production of structural malformations or defects in offspring After WHO, 1987 RT developmental toxicity, embryotoxicity
The production of physical defects in offspring in utero (i.e. causing birth defects). Teratogenicity is a potential side effect of some drugs, such as thalidomide.
The capacity of a physical or chemical agent to cause teratogenesis in offspring.
Property of an agent that causes physical defects in the developing embryo.